Colorectal cancer screening in Europe

被引：145

作者：

Zavoral, Miroslav ^{[1
]}

Suchanek, Stepan ^{[1
]}

Zavada, Filip ^{[1
]}

Dusek, Ladislav ^{[2
]}

Muzik, Jan ^{[2
]}

Seifert, Bohumil ^{[3
]}

Fric, Premysl ^{[1
]}

机构：

[1] Charles Univ Prague, Cent Mil Hosp, Fac Med 1, CZ-16902 Prague 6, Czech Republic

[2] Masaryk Univ, Inst Biostat & Anal, CZ-60200 Brno, Czech Republic

[3] Charles Univ Prague, Inst Gen Med, Fac Med 1, CZ-12800 Prague, Czech Republic

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2009年 / 15卷 / 47期

关键词：

Colorectal cancer; Europe; Fecal occult blood test; Screening colonoscopy; Screening programs; FECAL OCCULT BLOOD; PERIOD ANALYSIS; UNITED-STATES; SURVIVAL; POPULATION; PROGRAM; GASTROENTEROLOGY; COLONOSCOPY; EUROCARE-4; EXPERIENCE;

D O I：

10.3748/wjg.15.5907

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Colorectal cancer (CRC) is the second most frequent malignant disease in Europe. Every year, 412000 people are diagnosed with this condition, and 207000 patients die of it. In 2003, recommendations for screening programs were issued by the Council of the European Union (EU), and these currently serve as the basis for the preparation of European guidelines for CRC screening. The manner in which CRC screening is carried out varies significantly from country to country within the EU, both in terms of organization and the screening test chosen. A screening program of one sort or another has been implemented in 19 of 27 EU countries. The most frequently applied method is testing stool for occult bleeding (fecal occult blood test, FOBT). In recent years, a screening colonoscopy has been introduced, either as the only method (Poland) or the method of choice (Germany, Czech Republic). (C) 2009 The WJG Press and Baishideng. All rights reserved.

引用

页码：5907 / 5915

页数：9

共 40 条

[1] Stool DNA and occult blood testing for screen detection of colorectal neoplasia [J].